Amgen “Dear Doctor” Letter Warns Of Risk Of Death Associated With Aranesp
This article was originally published in The Pink Sheet Daily
Executive Summary
Letter follows release of data in patients receiving darbepoetin alfa who have anemia that is not due to concurrent chemotherapy, an off-label use.